Literature DB >> 15707357

Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome.

Wei-Jun Qian1, Tao Liu, Matthew E Monroe, Eric F Strittmatter, Jon M Jacobs, Lars J Kangas, Konstantinos Petritis, David G Camp, Richard D Smith.   

Abstract

Large-scale protein identifications from highly complex protein mixtures have recently been achieved using multidimensional liquid chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) and subsequent database searching with algorithms such as SEQUEST. Here, we describe a probability-based evaluation of false positive rates associated with peptide identifications from three different human proteome samples. Peptides from human plasma, human mammary epithelial cell (HMEC) lysate, and human hepatocyte (Huh)-7.5 cell lysate were separated by strong cation exchange (SCX) chromatography coupled offline with reversed-phase capillary LC-MS/MS analyses. The MS/MS spectra were first analyzed by SEQUEST, searching independently against both normal and sequence-reversed human protein databases, and the false positive rates of peptide identifications for the three proteome samples were then analyzed and compared. The observed false positive rates of peptide identifications for human plasma were significantly higher than those for the human cell lines when identical filtering criteria were used, suggesting that the false positive rates are significantly dependent on sample characteristics, particularly the number of proteins found within the detectable dynamic range. Two new sets of filtering criteria are proposed for human plasma and human cell lines, respectively, to provide an overall confidence of >95% for peptide identifications. The new criteria were compared, using a normalized elution time (NET) criterion (Petritis et al. Anal. Chem. 2003, 75, 1039-1048), with previously published criteria (Washburn et al. Nat. Biotechnol. 2001, 19, 242-247). The results demonstrate that the present criteria provide significantly higher levels of confidence for peptide identifications from mammalian proteomes without greatly decreasing the number of identifications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707357     DOI: 10.1021/pr0498638

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  159 in total

1.  Proteomic analysis of bronchoalveolar lavage fluid proteins from mice infected with Francisella tularensis ssp. novicida.

Authors:  Susan M Varnum; Bobbie-Jo M Webb-Robertson; Joel G Pounds; Ronald J Moore; Richard D Smith; Charles W Frevert; Shawn J Skerrett; David Wunschel
Journal:  J Proteome Res       Date:  2012-06-22       Impact factor: 4.466

2.  Increased power for the analysis of label-free LC-MS/MS proteomics data by combining spectral counts and peptide peak attributes.

Authors:  Lee Dicker; Xihong Lin; Alexander R Ivanov
Journal:  Mol Cell Proteomics       Date:  2010-09-07       Impact factor: 5.911

3.  Differential protein expression in Streptococcus uberis under planktonic and biofilm growth conditions.

Authors:  R C Crowley; J A Leigh; P N Ward; H M Lappin-Scott; L D Bowler
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

4.  Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size.

Authors:  Haizhen Zhang; Kristin E Burnum; Maria L Luna; Brianne O Petritis; Jong-Seo Kim; Wei-Jun Qian; Ronald J Moore; Alejandro Heredia-Langner; Bobbie-Jo M Webb-Robertson; Brian D Thrall; David G Camp; Richard D Smith; Joel G Pounds; Tao Liu
Journal:  Proteomics       Date:  2011-11-04       Impact factor: 3.984

5.  Non-enzymatic Lysine Lactoylation of Glycolytic Enzymes.

Authors:  Dominique O Gaffney; Erin Q Jennings; Colin C Anderson; John O Marentette; Taoda Shi; Anne-Mette Schou Oxvig; Matthew D Streeter; Mogens Johannsen; David A Spiegel; Eli Chapman; James R Roede; James J Galligan
Journal:  Cell Chem Biol       Date:  2019-11-22       Impact factor: 8.116

6.  Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform.

Authors:  Arthur D Tinoco; Debarati M Tagore; Alan Saghatelian
Journal:  J Am Chem Soc       Date:  2010-03-24       Impact factor: 15.419

7.  Proteomic identification and quantification of S-glutathionylation in mouse macrophages using resin-assisted enrichment and isobaric labeling.

Authors:  Dian Su; Matthew J Gaffrey; Jia Guo; Kayla E Hatchell; Rosalie K Chu; Therese R W Clauss; Joshua T Aldrich; Si Wu; Sam Purvine; David G Camp; Richard D Smith; Brian D Thrall; Wei-Jun Qian
Journal:  Free Radic Biol Med       Date:  2013-12-11       Impact factor: 7.376

8.  Systematic characterization of high mass accuracy influence on false discovery and probability scoring in peptide mass fingerprinting.

Authors:  Eric D Dodds; Brian H Clowers; Paul J Hagerman; Carlito B Lebrilla
Journal:  Anal Biochem       Date:  2007-10-11       Impact factor: 3.365

9.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

10.  Trauma-associated human neutrophil alterations revealed by comparative proteomics profiling.

Authors:  Jian-Ying Zhou; Ravi K Krovvidi; Yuqian Gao; Hong Gao; Brianne O Petritis; Asit K De; Carol L Miller-Graziano; Paul E Bankey; Vladislav A Petyuk; Carrie D Nicora; Therese R Clauss; Ronald J Moore; Tujin Shi; Joseph N Brown; Amit Kaushal; Wenzhong Xiao; Ronald W Davis; Ronald V Maier; Ronald G Tompkins; Wei-Jun Qian; David G Camp; Richard D Smith
Journal:  Proteomics Clin Appl       Date:  2013-05-22       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.